# Chemomab Therapeutics Ltd. (CMMB)

Source page: https://stoqly.net/companies/cmmb

- **Ticker:** CMMB (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001534248
- **Latest annual report:** 20-F filed 2026-03-23 (https://www.sec.gov/Archives/edgar/data/1534248/000117891326001593/zk2634510.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $1.16 on 2026-10-30 (+6.42% on the day)
- **Free cash flow:** −$11.1M
- **Return on equity:** −69.5%
- **Change in share count:** +42.1%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/cmmb/figures.csv

| US$ millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|
| Operating income | — | — | — | — | — | — | -103 | -112 |
| Net income | -14 | -27 | -6 | -12 | -28 | -24 | -14 | -9 |
| Diluted EPS (US$) | 1.09 | 0.79 | 0.04 | 0.06 | 0.12 | 0.10 | 0.04 | 0.02 |
| Operating cash flow | -14 | -16 | -5 | -12 | -20 | -24 | -15 | -11 |
| Free cash flow | -14 | -17 | -5 | -13 | -20 | -24 | -15 | -11 |
| Cash | 8 | 18 | 12 | 15 | 14 | 9 | 6 | 8 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.